(Q33424940)

26 July 2017

The role of N-acetylcysteine in the treatment of thrombotic thrombocytopenic purpura (English)

1 reference

thrombotic thrombocytopenic purpura

26 July 2017

1 reference

1 reference

1 reference

Yosef Kalish

4

0 references

author name string

Amihai Rottenstreich

series ordinal

1

1 reference

PubMed ID

26245827

26 July 2017

Sarit Hochberg-Klein

series ordinal

2

1 reference

PubMed ID

26245827

26 July 2017

Deborah Rund

series ordinal

3

1 reference

26 July 2017

7 August 2015

1 reference

Journal of Thrombosis and Thrombolysis

26 July 2017

1 reference

26 July 2017

41

1 reference

26 July 2017

4

1 reference

26 July 2017

678-683

1 reference

https://scigraph.springernature.com/pub.10.1007/s11239-015-1259-6

26 July 2017

0 references

cites work

Thrombotic thrombocytopenic purpura: early and late responders

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

How I treat refractory thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

Treatment of refractory thrombotic thrombocytopenic purpura with N-acetylcysteine: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

How I treat patients with thrombotic thrombocytopenic purpura: 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1259-6

N-Acetylcysteine for thrombotic thrombocytopenic purpura: is a von Willebrand factor-inhibitory dose feasible in vivo?

21 January 2018

1 reference

12 December 2020

Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura

1 reference

12 December 2020

The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm

1 reference

12 December 2020

The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects

1 reference

12 December 2020

Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes

1 reference

12 December 2020

10.1007/S11239-015-1259-6

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

26245827